Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Hepatocellular 36Carcinoma, Non-Small-Cell Lung 17Small Cell Lung Carcinoma 16Neoplasms 14Lung Neoplasms 13Breast Neoplasms 8Melanoma 6Colorectal Neoplasms 6Carcinoma, Renal Cell 6Prostatic Neoplasms 5Liver Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Neoplasm Metastasis 4Head and Neck Neoplasms 4Glioblastoma 4Endometrial Neoplasms 4Recurrence 3Ovarian Neoplasms 3Neoplasms by Site 3Neoplasms by Histologic Type 3Carcinoma, Transitional Cell 3Uterine Cervical Neoplasms 2Urogenital Neoplasms 2Small Cell Lung Cancer Extensive Stage 2Sarcoma, Alveolar Soft Part 2Osteosarcoma 2Mesothelioma, Malignant 2Mesothelioma 2

Interventions

Carboplatin 5Nivolumab 4pembrolizumab 3Pemetrexed 3Ipilimumab 3fludarabine 2atezolizumab 2Cyclophosphamide 2Cisplatin 2tremelimumab 1sotorasib 1osimertinib 1olaparib 1durvalumab 1Tumor Burden 1Thoracoscopy 1Tablets 1Saline Solution 1Quality of Life 1Observation 1Magnesium Sulfate 1Injections 1Influenza Vaccines 1Histocompatibility Testing 1Gemcitabine 1Fluorodeoxyglucose F18 1Exercise Therapy 1Combined Modality Therapy 1Cell- and Tissue-Based Therapy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Mesothelioma × atezolizumab × Clear all
NCT06444815 2026-04-07

STEALTH-001

KaliVir Immunotherapeutics

Phase 1 Recruiting
60 enrolled
DermatologicGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Kidney Neoplasms, Melanoma, Mesothelioma

NCT04996017 2025-03-13

AtezoMeso

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 3 Recruiting
162 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡